文献速递神经儿科影像MR

儿童低级别胶质瘤的MR影像特征及ADC直方图参数用于区分分子亚组

MR Imaging Characteristics and ADC Histogram Metrics for Differentiating Molecular Subgroups of Pediatric Low-Grade Gliomas.
PubMed 文献 · AJNR Am J Neuroradiol · 2022-08-25

回顾性分析40例儿童低级别胶质瘤,评估常规MRI特征及ADC直方图参数与BRAF突变和1型神经纤维瘤病状态的关系。结果显示扩散直方图指标(均值、中位数、第10和第90百分位数)在亚组间有差异,BRAF V600E突变肿瘤扩散最低(第10百分位数AUC=0.9),边缘清晰和囊性成分也与分子亚组相关。

要点

  • ADC直方图第10百分位数有助于识别BRAF V600E突变型儿童低级别胶质瘤。
  • 边缘清晰更常见于BRAF-KIAA或野生型,而非BRAF V600E突变或1型神经纤维瘤病肿瘤。
  • 1型神经纤维瘤病相关肿瘤均未出现囊性成分。

关键影像表现/征象

  • 扩散直方图指标(均值、中位数、第10和第90百分位数)在儿童低级别胶质瘤亚组间不同(P < .05),而峰度和偏度无差异。
  • BRAF V600E突变肿瘤扩散最低,第10百分位数在ROC分析中AUC达0.9。
  • 肿瘤边缘和囊性成分在评估的儿童低级别胶质瘤亚组间有显著差异(P = .03和P = .001)。
  • 边缘清晰为BRAF-KIAA或野生型BRAF特征,而非BRAF V600E突变或1型神经纤维瘤病肿瘤。
  • 1型神经纤维瘤病肿瘤均无囊性成分。

诊断标准与关键数值

  • ADC直方图第10百分位数区分BRAF V600E突变肿瘤的AUC为0.9(ROC分析)。

临床应用与阅片要点

  • 阅片时关注肿瘤边缘和囊性成分,结合ADC直方图指标(尤其第10百分位数)辅助预测分子亚型。
  • 对疑似儿童低级别胶质瘤,可建议ADC直方图分析以提示BRAF或1型神经纤维瘤病状态。

局限性

  • 回顾性研究,样本量有限(40例),部分1型神经纤维瘤病诊断未经活检证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: BRAF and type 1 neurofibromatosis status are distinctive features in pediatric low-grade gliomas with prognostic and therapeutic implications. We hypothesized that DWI metrics obtained through volumetric ADC histogram analyses of pediatric low-grade gliomas at baseline would enable early detection of BRAF and type 1 neurofibromatosis status.

MATERIALS AND METHODS: We retrospectively evaluated 40 pediatric patients with histologically proved pilocytic astrocytoma (n = 33), ganglioglioma (n = 4), pleomorphic xanthoastrocytoma (n = 2), and diffuse astrocytoma grade 2 (n = 1). Apart from 1 patient with type 1 neurofibromatosis who had a biopsy, 11 patients with type 1 neurofibromatosis underwent conventional MR imaging to diagnose a low-grade tumor without a biopsy. BRAF molecular analysis was performed for patients without type 1 neurofibromatosis. Eleven patients presented with BRAF V600E-mutant, 20 had BRAF-KIAA rearrangement, and 8 had BRAF wild-type tumors. Imaging studies were reviewed for location, margins, hemorrhage or calcifications, cystic components, and contrast enhancement. Histogram analysis of tumoral diffusivity was performed.

RESULTS: Diffusion histogram metrics (mean, median, and 10th and 90th percentiles) but not kurtosis or skewness were different among pediatric low-grade glioma subgroups (P < .05). Diffusivity was lowest in BRAF V600E-mutant tumors (the 10th percentile reached an area under the curve of 0.9 on receiver operating characteristic analysis). There were significant differences between evaluated pediatric low-grade glioma margins and cystic components (P = .03 and P = .001, respectively). Well-defined margins were characteristic of BRAF-KIAA or wild-type BRAF rather than BRAF V600E-mutant or type 1 neurofibromatosis tumors. None of the type 1 neurofibromatosis tumors showed a cystic component.

CONCLUSIONS: Imaging features of pediatric low-grade gliomas, including quantitative diffusion metrics, may assist in predicting BRAF and type 1 neurofibromatosis status, suggesting a radiologic-genetic correlation, and might enable early genetic signature characterization.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Shrot, Kerpel, Belenky, et al. MR Imaging Characteristics and ADC Histogram Metrics for Differentiating Molecular Subgroups of Pediatric Low-Grade Gliomas. AJNR Am J Neuroradiol. 2022. PMID: 36007944. doi:10.3174/ajnr.A7614

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。